Logo for Glaukos Corporation

Glaukos Investor Relations Material

Latest events

Logo for Glaukos Corporation

Q1 2024

Glaukos
Logo for Glaukos

Q1 2024

1 May, 2024
Logo for Glaukos

Q4 2023

21 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Glaukos Corporation

Access all reports
Glaukos Corporation is a clinical-stage medical device company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, corneal disorders and retinal diseases. Glaukos is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment and management of glaucoma, corneal disorders and retinal diseases.